Company Valuation: Haisco Pharmaceutical Group Co., Ltd.

Data adjusted to current consolidation scope
Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027
Capitalization 1 18,638 21,747 23,695 25,545 36,883 54,420 - -
Change - 16.68% 8.96% 7.81% 44.38% 47.55% - -
Enterprise Value (EV) 18,638 21,747 23,695 25,545 36,883 54,420 54,420 54,420
Change - 16.68% 8.96% 7.81% 44.38% 47.55% 0% 0%
P/E ratio 30.2x 63.8x 85.6x 85.7x 95x 96.8x 73.6x 56x
PBR 6.46x 7.73x - 6.17x 8.84x 11.7x 9.71x 9.14x
PEG - -1.4x -4.6x 22.28x 3.2x 2.2x 2.3x 1.8x
Capitalization / Revenue 5.59x 7.84x - 7.61x 9.91x 12.2x 10.1x 8.37x
EV / Revenue 0x 0x - 0x 0x 12.2x 10.1x 8.37x
EV / EBITDA 0x 0x - 0x 0x 67.8x 51.4x 38.1x
EV / EBIT 0x 0x - 0x 0x 82.5x 62.8x 47.6x
EV / FCF - - - - 0x 104x 90x 65.3x
FCF Yield - - - - 0.09% 0.96% 1.11% 1.53%
Dividend per Share 2 - - - 0.2 0.135 0.07 0.045 0.12
Rate of return - - - 0.86% 0.41% 0.14% 0.09% 0.24%
EPS 2 0.58 0.32 0.26 0.27 0.35 0.5067 0.6667 0.8767
Distribution rate - - - 74.1% 38.6% 13.8% 6.75% 13.7%
Net sales 1 3,337 2,773 - 3,355 3,721 4,446 5,389 6,500
EBITDA 1 805.9 691.9 - 529.1 463.3 802.4 1,058 1,427
EBIT 1 692.2 512.3 - 313.5 507.4 659.4 867.1 1,143
Net income 1 618.4 345.1 277 295.1 395.5 567.7 743 980.3
Net Debt - - - - - - - -
Reference price 2 17.52 20.40 22.25 23.15 33.25 49.06 49.06 49.06
Nbr of stocks (in thousands) 1,063,821 1,066,028 1,064,949 1,103,460 1,109,260 1,109,260 - -
Announcement Date 2/26/21 4/26/22 4/17/23 4/19/24 4/11/25 - - -
1CNY in Million2CNY
Estimates

P/E ratio, Detailed evolution

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
96.83x - - 0.14% 7.58B
36.13x11.98x27.23x0.77% 693B
14.63x4.31x11.78x3.15% 394B
27.14x6.49x13.73x3.45% 334B
15.94x5.78x11.57x3.18% 287B
14.37x3.52x8.72x3.82% 259B
16.56x4.4x10.31x3.49% 223B
21.78x4.08x12x2.32% 215B
10.26x3.33x7.2x4.02% 201B
22.54x5.77x11.13x3.25% 158B
Average 27.62x 5.52x 12.63x 2.76% 277.25B
Weighted average by Cap. 22.69x 6.58x 15.11x 2.68%
See all sector valuations

Year-on-year evolution of the PER

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Equities
  3. 002653 Stock
  4. Valuation Haisco Pharmaceutical Group Co., Ltd.